Navigation Links
Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
Date:12/24/2007

BEIJING, Dec. 24 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced positive top-line results of completed Phase II clinical trial of its pandemic influenza (H5N1) whole viron inactivated vaccine. The stratified, randomized, double-blind trial of the vaccine was designed to assess the safety and immunogenicity of the vaccine.

Sinovac received approval from the China State Food and Drug Administration (SFDA) in April 2007 to conduct Phase Ib and II trials of the H5N1 whole viron vaccine and Phase I and Phase II trials of the H5N1 split vaccine.

The Phase II trial of the H5N1 whole viron inactivated vaccine was conducted by Beijing Centers for Disease Control and Prevention. It included 402 volunteers, between the ages of 18 and 60, who were each vaccinated with two doses of 5 ug, 10 ug or 15 ug. The preliminary results of the trials suggested that each of the three dosages can induce varying degrees of immune response. In particular, the anti-HI seroconversion rate, the increasing GMT and protection rate of the H5N1 whole viron inactivated vaccines for the 10ug and 15ug dosages reached the EMEA evaluation standards of seasonal flu vaccines, which is an indication of good immunogenicity of the vaccine. The trial result did not show any serious adverse reaction among volunteers, suggesting the vaccine's good safety profile.

In addition, Sinovac recently completed the phase I clinical trial of the split H5N1 vaccine. The result of vaccinations on children, adults and elderly with candidate vaccines of different dosage indicated that the split H5N1 vaccine is safe for human use.

Mr. Weidong Yin, Chairman, President and CEO, stated, "We are very pleased with the achievements of our team that led to the development of a pandemic influenza vaccine. After Phase II clinical trials of the whole viron H5N1 vaccine, the vaccine dosages and schedule can now be determined. This accomp
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sinovac Announces Postponement of Annual General Meeting
2. Sinovac Requests Extension for Annual Shareholders Meeting
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...ROCKVILLE, Md., Nov. 30 ...ccine company, announced today that the company wi...nference 2009 on December 2, 2009 at 12:30 pm loca...will provide an overview of the company,s business...pcoming milestones. A link to the live audio only...
(Date:11/30/2009)...ROCKVILLE, Md., Nov. 30 ...has completed enrollment in the Phase II clinical ...09 recommended strains) VLP vaccine candidate in h...ts). This randomized, double-blind, active-contro...nd immunogenicity of two different doses (15 mcg a...
(Date:11/30/2009)..., SHANGHAI, Nov. 30 /PRNewswire-Asia/ -- WuX...al, biotechnology, and medical-device research and...n China and the United States,announced that it h...0 China,2009 list for the fifth consecutive year. ...es in China,s technology, media, and telecommunica...
(Date:11/27/2009)..., DURHAM, N.C., Nov. 27 Cromoz ...iate water-soluble carbon nanotube-based cancer dr...soluble carbon nanotubes, which have functional gr... cancer drugs, was developed in partnership with t...d carbon nanotubes serves as a drug delivery vehic...
Breaking Biology Technology:NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2
...d Wave Technologies , compensation in a patent law... legal fees. Stratagene is proceeding with its app... the judge found that Stratagene willfully infring...ethods, and awarded Madison-based Third Wave $5.3 ...Invader line of products. Stratagene was given an ...
...ur taxes supporting? , ,This question becomes very...urced to other countries by the thousands and many...ats important. Educators better get with the progr...bility to learn and compete. , ,The latest decisio...now includes Bank One) to shift 7,000 financial jo...
...omote your business than by writing good, helpful ...d content attracts good traffic. , ,On an average ...Internet, according to the PEW Internet and Ameri... activities include getting news and finding infor...e got good content on your site, that can be found...
Other Biology Technology:With flawed schools exposed, real-world experience is needed 2With flawed schools exposed, real-world experience is needed 3With flawed schools exposed, real-world experience is needed 4The write stuff: marketing with articles 2The write stuff: marketing with articles 3The write stuff: marketing with articles 4
(Date:11/30/2009)...tive gas that is produced by the radioactive decay...nd is found in trace amounts naturally in nearly a...ng materials, plants, animals, and the human body....nt of radiation that would be emitted by radon and...its are picocuries per liter (pCi/L). The American...
(Date:11/26/2009)...er have been caught in the hunters, sights for gen...decorative. They are lethal weapons that stags cra...niversity of York, UK, has been intrigued by the m...ry and has become fascinated by the mechanical pro...ation with Tomas Landete-Castillejos at the Univer...
(Date:11/26/2009)...tries has shown that closing schools in the event ...nificant role in reducing illness transmission. Re...Infectious Diseases compared opportunities for in...ing that they were reduced when schools are shut. ..., Belgium, led a team of European researchers in u...
Breaking Biology News(10 mins):Health Physics Society recommends considering action for indoor radon below current guidelines 2Tough yet stiff deer antler is materials scientist's dream 2School closure could reduce swine flu transmission by 21 percent 2Seattle Software Firm Claims to Cure What Ails Health Care 55353 1Seattle Software Firm Claims to Cure What Ails Health Care 55353 2GlaxoSmithKline Statement Confirming alli Safety 55350 1As Waistlines Widen Brains Shrink 55347 1As Waistlines Widen Brains Shrink 55347 2As Waistlines Widen Brains Shrink 55347 3
... Next month in Boston, the AVS 55th International ... across the spectrum of science and engineering de...nterfaces, in plasmas, and in other controlled env...logies. , AVS is an interdisciplinary nonprofit ...iversities, government agencies, and industrial la...
...active oxygen species (ROS) occur as a by-product ... by damaging proteins, nucleotides and lipids. Or...ms to mitigate the effects of ROS, and the oxidati...hat physiological performance declines with age du...ogressively limited anti-oxidant capacity. Hence,...
...bal Carbon Budget was launched simultaneously by G...rance at the Paris Observatory, and in the USA at ... Pep Canadell. , The Global Carbon Project posted...dget, a key to understanding the balance of carbon...n induced climate change. Despite the increasing i...
Other Biology News:Save-the-date: Major nanotech, energy, and biomed meeting 2Save-the-date: Major nanotech, energy, and biomed meeting 3Save-the-date: Major nanotech, energy, and biomed meeting 4Researchers discover that growing up too fast may mean dying young in honey bees 2Researchers discover that growing up too fast may mean dying young in honey bees 3Growth in the global carbon budget 2
Polystyrene Plate Cover from ABgene
Polypropylene Plate Cover from ABgene
... polymer with a unique split septum design. Feat... tall-chimney plates (AB-0937, AB-1055, AB-1056) ...ew or clip-down hot lid thermal cyclers Pierceabl...ps may be pierced simultaneously Less than 0.5N ...
...native to traditional TBE (TRIS borate-EDTA) and T...onic Buffer allows for higher voltage runs, extrem...separation. -Application: Ready for use in gel ele...ations. Caution: Test electrophoresis chambers t...
Biology Products: